vTv Therapeutics Inc. (VTVT)

USD 16.47

(-5.83%)

Total Assets Summary of vTv Therapeutics Inc.

  • vTv Therapeutics Inc.'s latest annual total assets in 2023 was 11.01 Million USD , down -66.85% from previous year.
  • vTv Therapeutics Inc.'s latest quarterly total assets in 2024 Q2 was 46.45 Million USD , down -14.26% from previous quarter.
  • vTv Therapeutics Inc. reported annual total assets of 33.23 Million USD in 2022, up 30.48% from previous year.
  • vTv Therapeutics Inc. reported annual total assets of 25.47 Million USD in 2021, up 72.25% from previous year.
  • vTv Therapeutics Inc. reported quarterly total assets of 54.18 Million USD for 2024 Q1, up 391.77% from previous quarter.
  • vTv Therapeutics Inc. reported quarterly total assets of 22.42 Million USD for 2023 Q2, down -22.21% from previous quarter.

Annual Total Assets Chart of vTv Therapeutics Inc. (2023 - 2013)

Historical Annual Total Assets of vTv Therapeutics Inc. (2023 - 2013)

Year Total Assets Total Assets Growth
2023 11.01 Million USD -66.85%
2022 33.23 Million USD 30.48%
2021 25.47 Million USD 72.25%
2020 14.78 Million USD 59.61%
2019 9.26 Million USD 8.26%
2018 8.55 Million USD -69.34%
2017 27.91 Million USD -48.77%
2016 54.49 Million USD -40.46%
2015 91.53 Million USD 606.76%
2014 12.95 Million USD -16.47%
2013 15.5 Million USD 0.0%

Peer Total Assets Comparison of vTv Therapeutics Inc.

Name Total Assets Total Assets Difference
AbCellera Biologics Inc. 1.48 Billion USD 99.26%
Alkermes plc 2.13 Billion USD 99.484%
Agenus Inc. 313.91 Million USD 96.49%
Alnylam Pharmaceuticals, Inc. 3.82 Billion USD 99.712%
Aptorum Group Limited 20.64 Million USD 46.618%
Ardelyx, Inc. 297.57 Million USD 96.297%
Arrowhead Pharmaceuticals, Inc. 765.55 Million USD 98.561%
Bicycle Therapeutics plc 595.34 Million USD 98.149%
BioXcel Therapeutics, Inc. 73.7 Million USD 85.051%
ChromaDex Corporation 54.96 Million USD 79.954%
Chimerix, Inc. 212.77 Million USD 94.822%
Corbus Pharmaceuticals Holdings, Inc. 28.27 Million USD 61.029%
Caribou Biosciences, Inc. 440.96 Million USD 97.501%
CRISPR Therapeutics AG 2.22 Billion USD 99.506%
Precision BioSciences, Inc. 159.78 Million USD 93.104%
Dyadic International, Inc. 8.21 Million USD -34.051%
Eton Pharmaceuticals, Inc. 31.74 Million USD 65.287%
Fortress Biotech, Inc. 167.52 Million USD 93.423%
Lantern Pharma Inc. 43.64 Million USD 74.757%
HOOKIPA Pharma Inc. 161.33 Million USD 93.171%
Inhibikase Therapeutics, Inc. 14.5 Million USD 24.049%
Incyte Corporation 6.78 Billion USD 99.838%
IO Biotech, Inc. 150.71 Million USD 92.69%
Jaguar Health, Inc. 50.76 Million USD 78.295%
Novavax, Inc. 1.85 Billion USD 99.406%
Janux Therapeutics, Inc. 380.4 Million USD 97.104%
Opthea Limited 188.79 Million USD 94.164%
Ligand Pharmaceuticals Incorporated 833.06 Million USD 98.677%
ContextLogic Inc. 423 Million USD 97.395%
MiMedx Group, Inc. 239.04 Million USD 95.391%
Pyxis Oncology, Inc. 173.72 Million USD 93.658%
TransCode Therapeutics, Inc. 5.16 Million USD -113.126%
NextCure, Inc. 129.41 Million USD 91.487%
Ocuphire Pharma, Inc. 53.94 Million USD 79.577%
Oncternal Therapeutics, Inc. 36.72 Million USD 70.002%
Outlook Therapeutics, Inc. 32.3 Million USD 65.89%
Vaxcyte, Inc. 1.4 Billion USD 99.217%
PDS Biotechnology Corporation 59.39 Million USD 81.448%
Madrigal Pharmaceuticals, Inc. 640.54 Million USD 98.28%
Pharming Group N.V. 462.85 Million USD 97.62%
Pieris Pharmaceuticals, Inc. 38.68 Million USD 71.515%
Avidity Biosciences, Inc. 628.55 Million USD 98.247%
Reviva Pharmaceuticals Holdings, Inc. 18.92 Million USD 41.777%
Reviva Pharmaceuticals Holdings, Inc. 18.92 Million USD 41.777%
Sangamo Therapeutics, Inc. 165.32 Million USD 93.335%
Sol-Gel Technologies Ltd. 45.28 Million USD 75.671%
Acelyrin, Inc. 742.69 Million USD 98.516%
Salarius Pharmaceuticals, Inc. 6.58 Million USD -67.281%
SELLAS Life Sciences Group, Inc. 6.4 Million USD -72.076%
Summit Therapeutics Inc. 202.94 Million USD 94.571%
Sensei Biotherapeutics, Inc. 74.37 Million USD 85.186%
Senti Biosciences, Inc. 119.48 Million USD 90.779%
Stoke Therapeutics, Inc. 228.34 Million USD 95.175%
Syros Pharmaceuticals, Inc. 168.17 Million USD 93.448%
Alaunos Therapeutics, Inc. 8.26 Million USD -33.341%
Telomir Pharmaceuticals, Inc. Common Stock 4.77 Million USD -130.803%
Entrada Therapeutics, Inc. 469.19 Million USD 97.652%
VistaGen Therapeutics, Inc. 123.65 Million USD 91.09%
Wave Life Sciences Ltd. 274.94 Million USD 95.993%
Sorrento Therapeutics, Inc. 472.84 Million USD 97.67%
TRACON Pharmaceuticals, Inc. 10.1 Million USD -9.035%
Barinthus Biotherapeutics plc 214.5 Million USD 94.864%
Psyence Biomedical Ltd. 1.13 Million USD -873.185%
Phathom Pharmaceuticals, Inc. 413.84 Million USD 97.338%
Immix Biopharma, Inc. 19.92 Million USD 44.703%
Keros Therapeutics, Inc. 370.02 Million USD 97.022%
MEI Pharma, Inc. 41.37 Million USD 73.37%
Windtree Therapeutics, Inc. 32.4 Million USD 66.0%
Xeris Biopharma Holdings, Inc. 340.79 Million USD 96.767%
Rigel Pharmaceuticals, Inc. 117.22 Million USD 90.601%
Fortress Biotech, Inc. 167.52 Million USD 93.423%
Precigen, Inc. 151.04 Million USD 92.705%
Clearside Biomedical, Inc. 34.01 Million USD 67.611%
AlloVir, Inc. 190.79 Million USD 94.225%
C4 Therapeutics, Inc. 376.45 Million USD 97.073%
Fate Therapeutics, Inc. 506.21 Million USD 97.823%
ImmuCell Corporation 43.8 Million USD 74.849%
IDEAYA Biosciences, Inc. 649.31 Million USD 98.303%
Onconetix, Inc. 88.82 Million USD 87.595%
PureTech Health plc 693.97 Million USD 98.412%
VYNE Therapeutics Inc. 97.68 Million USD 88.721%
Elevation Oncology, Inc. 89.09 Million USD 87.633%
Kintara Therapeutics, Inc. 6.2 Million USD -77.652%
Seer, Inc. 436.26 Million USD 97.474%
Verrica Pharmaceuticals Inc. 81.59 Million USD 86.497%
Innoviva, Inc. 1.24 Billion USD 99.114%
Aadi Bioscience, Inc. 132.42 Million USD 91.68%
ESSA Pharma Inc. 149.12 Million USD 92.611%
GlycoMimetics, Inc. 45.31 Million USD 75.687%
GT Biopharma, Inc. 14.1 Million USD 21.908%
Inhibrx Biosciences, Inc. 307.89 Million USD 96.421%
Akebia Therapeutics, Inc. 241.7 Million USD 95.442%
Catalyst Pharmaceuticals, Inc. 471.9 Million USD 97.665%
Longboard Pharmaceuticals, Inc. 50.69 Million USD 78.267%
Orchestra BioMed Holdings, Inc. 95.21 Million USD 88.428%
Alzamend Neuro, Inc. 631.58 Thousand USD -1644.492%
Rocket Pharmaceuticals, Inc. 566.34 Million USD 98.055%
Aptose Biosciences Inc. 12.92 Million USD 14.738%
ZyVersa Therapeutics, Inc. 22.11 Million USD 50.177%
Soligenix, Inc. 9.79 Million USD -12.459%
Century Therapeutics, Inc. 360.69 Million USD 96.945%
Kura Oncology, Inc. 448.93 Million USD 97.546%
TScan Therapeutics, Inc. 272.14 Million USD 95.951%
Intensity Therapeutics, Inc. 17.29 Million USD 36.294%
Ocean Biomedical, Inc. 110.91 Million USD 90.066%
CytomX Therapeutics, Inc. 205.15 Million USD 94.629%
Autolus Therapeutics plc 375.38 Million USD 97.065%
Mineralys Therapeutics, Inc. 251.63 Million USD 95.621%
EyePoint Pharmaceuticals, Inc. 355.18 Million USD 96.898%
Eterna Therapeutics Inc. 49.13 Million USD 77.575%
Adaptive Biotechnologies Corporation 661.13 Million USD 98.333%
GRI Bio, Inc. 2.95 Million USD -272.733%
Xenetic Biosciences, Inc. 10.6 Million USD -3.892%
Tenaya Therapeutics, Inc. 170.51 Million USD 93.538%
IGM Biosciences, Inc. 423.41 Million USD 97.398%
INmune Bio, Inc. 57 Million USD 80.671%
Heron Therapeutics, Inc. 222.5 Million USD 95.048%
SAB Biotherapeutics, Inc. 83.94 Million USD 86.874%
Pasithea Therapeutics Corp. 26.11 Million USD 57.813%
Entero Therapeutics, Inc. 6.88 Million USD -60.071%
Milestone Pharmaceuticals Inc. 75.22 Million USD 85.353%
X4 Pharmaceuticals, Inc. 147.25 Million USD 92.518%
Atara Biotherapeutics, Inc. 165.5 Million USD 93.343%
Coherus BioSciences, Inc. 629.6 Million USD 98.25%
Verastem, Inc. 149.71 Million USD 92.641%
Abeona Therapeutics Inc. 64 Million USD 82.785%
Pliant Therapeutics, Inc. 512.15 Million USD 97.849%
Tonix Pharmaceuticals Holding Corp. 154.45 Million USD 92.867%
Histogen Inc. 19.07 Million USD 42.232%
Aprea Therapeutics, Inc. 22.65 Million USD 51.356%
Surrozen, Inc. 46.08 Million USD 76.089%
Organovo Holdings, Inc. 6.34 Million USD -73.539%
Lixte Biotechnology Holdings, Inc. 4.3 Million USD -155.72%
Ovid Therapeutics Inc. 144.02 Million USD 92.35%
Panbela Therapeutics, Inc. 11.8 Million USD 6.643%
CASI Pharmaceuticals, Inc. 75.26 Million USD 85.362%
Cadrenal Therapeutics, Inc. Common Stock 8.51 Million USD -29.331%
Centessa Pharmaceuticals plc 362.96 Million USD 96.964%
Hepion Pharmaceuticals, Inc. 18.09 Million USD 39.108%
Arcturus Therapeutics Holdings Inc. 429.4 Million USD 97.434%
BioRestorative Therapies, Inc. 12.61 Million USD 12.637%
Apollomics, Inc. 55.38 Million USD 80.107%
Amarin Corporation plc 831.68 Million USD 98.675%
Mesoblast Limited 669.15 Million USD 98.353%
Turnstone Biologics Corp. 112.81 Million USD 90.234%
Kymera Therapeutics, Inc. 575.75 Million USD 98.086%
Synaptogenix, Inc. 31.11 Million USD 64.588%
Tiziana Life Sciences Ltd 12.18 Million USD 9.57%
Aurinia Pharmaceuticals Inc. 548.06 Million USD 97.99%
BriaCell Therapeutics Corp. 5.87 Million USD -87.628%
Monopar Therapeutics Inc. 7.34 Million USD -50.004%
Exelixis, Inc. 2.94 Billion USD 99.626%
Better Therapeutics, Inc. 22.94 Million USD 51.977%
Nurix Therapeutics, Inc. 364.53 Million USD 96.978%
Apellis Pharmaceuticals, Inc. 788.73 Million USD 98.603%
NLS Pharmaceutics AG 1.84 Million USD -496.651%
Dermata Therapeutics, Inc. 7.97 Million USD -38.094%
Aridis Pharmaceuticals, Inc. 14.69 Million USD 25.022%
Gritstone bio, Inc. 177.76 Million USD 93.802%
Jasper Therapeutics, Inc. 95.38 Million USD 88.448%
TNF Pharmaceuticals, Inc. 17.86 Million USD 38.317%
Avid Bioservices, Inc. 336.55 Million USD 96.726%
Insmed Incorporated 1.32 Billion USD 99.171%
Virpax Pharmaceuticals, Inc. 9.62 Million USD -14.433%
MediWound Ltd. 66.45 Million USD 83.421%
OmniAb, Inc. 401.98 Million USD 97.259%
Alector, Inc. 621.82 Million USD 98.228%
Seres Therapeutics, Inc. 358.6 Million USD 96.927%
Checkpoint Therapeutics, Inc. 5.37 Million USD -104.872%
Viracta Therapeutics, Inc. 56.69 Million USD 80.565%
Zai Lab Limited 1.03 Billion USD 98.937%
Revance Therapeutics, Inc. 478.45 Million USD 97.697%
Aura Biosciences, Inc. 255.07 Million USD 95.68%
Lyell Immunopharma, Inc. 750.02 Million USD 98.531%
Immunic, Inc. 54.29 Million USD 79.709%
Tarsus Pharmaceuticals, Inc. 266.22 Million USD 95.861%
Veracyte, Inc. 1.13 Billion USD 99.032%
InMed Pharmaceuticals Inc. 11.82 Million USD 6.807%
FibroGen, Inc. 423.52 Million USD 97.399%
SeaStar Medical Holding Corporation 3.51 Million USD -213.635%
Adial Pharmaceuticals, Inc. 4.73 Million USD -132.614%
Sonnet BioTherapeutics Holdings, Inc. 5.42 Million USD -102.929%
Jazz Pharmaceuticals plc 11.39 Billion USD 99.903%
Cyclacel Pharmaceuticals, Inc. 8.8 Million USD -25.133%
Amylyx Pharmaceuticals, Inc. 517.45 Million USD 97.871%
TG Therapeutics, Inc. 329.58 Million USD 96.657%
Galecto, Inc. 38.22 Million USD 71.177%
Calithera Biosciences, Inc. 28.67 Million USD 61.578%
Fortrea Holdings Inc. 4.35 Billion USD 99.747%
KalVista Pharmaceuticals, Inc. 235.4 Million USD 95.32%
Aptevo Therapeutics Inc. 24.84 Million USD 55.648%
XBiotech Inc. 227.24 Million USD 95.151%
Jasper Therapeutics, Inc. 95.38 Million USD 88.448%
Lyra Therapeutics, Inc. 142.6 Million USD 92.273%
Foghorn Therapeutics Inc. 285.91 Million USD 96.146%
Y-mAbs Therapeutics, Inc. 127.86 Million USD 91.383%
Theravance Biopharma, Inc. 381.99 Million USD 97.116%
Ultragenyx Pharmaceutical Inc. 1.49 Billion USD 99.261%
Metagenomi, Inc. Common Stock 364.84 Million USD 96.98%
Vaxxinity, Inc. 44.35 Million USD 75.158%
BioCryst Pharmaceuticals, Inc. 516.96 Million USD 97.869%
Gain Therapeutics, Inc. 18.6 Million USD 40.793%
Cartesian Therapeutics, Inc. 305.05 Million USD 96.388%
NexImmune, Inc. 8.59 Million USD -28.206%
Creative Medical Technology Holdings, Inc. 10.71 Million USD -2.826%
Marker Therapeutics, Inc. 17.12 Million USD 35.67%
Regeneron Pharmaceuticals, Inc. 33.08 Billion USD 99.967%
Chemomab Therapeutics Ltd. 22.15 Million USD 50.26%
Scopus BioPharma Inc. 392.26 Thousand USD -2708.815%
RAPT Therapeutics, Inc. 173.32 Million USD 93.643%
Ainos, Inc. 31.84 Million USD 65.398%
Pluri Inc. 39.52 Million USD 72.125%
Prothena Corporation plc 696.38 Million USD 98.418%
Adaptimmune Therapeutics plc 282.61 Million USD 96.101%
Celularity Inc. 143.88 Million USD 92.343%
Rallybio Corporation 115.62 Million USD 90.471%
Cue Biopharma, Inc. 61.53 Million USD 82.093%
MeiraGTx Holdings plc 458.16 Million USD 97.595%
Omeros Corporation 378.26 Million USD 97.087%
Humacyte, Inc. 128.22 Million USD 91.407%
Immunocore Holdings plc 597 Million USD 98.154%
Cocrystal Pharma, Inc. 31.25 Million USD 64.753%
Cidara Therapeutics, Inc. 68.53 Million USD 83.922%
Blueprint Medicines Corporation 1.04 Billion USD 98.95%
CalciMedica, Inc. 12.18 Million USD 9.577%
Cabaletta Bio, Inc. 253.65 Million USD 95.656%
Marinus Pharmaceuticals, Inc. 170.9 Million USD 93.553%
Scholar Rock Holding Corporation 311.03 Million USD 96.458%
Sana Biotechnology, Inc. 565.29 Million USD 98.051%
Pulmatrix, Inc. 33.95 Million USD 67.554%
Elicio Therapeutics, Inc. 27.14 Million USD 59.412%
Vigil Neuroscience, Inc. 140.85 Million USD 92.178%
Intellia Therapeutics, Inc. 1.3 Billion USD 99.153%
Adlai Nortye Ltd. American Depositary Shares 130.18 Million USD 91.537%
Cytokinetics, Incorporated 824.31 Million USD 98.663%
Eloxx Pharmaceuticals, Inc. 21.12 Million USD 47.839%
Nutriband Inc. 7.51 Million USD -46.571%
Protara Therapeutics, Inc. 78.95 Million USD 86.045%
Vor Biopharma Inc. 209.82 Million USD 94.749%
Roivant Sciences Ltd. 7.22 Billion USD 99.847%
Evogene Ltd. 51.1 Million USD 78.439%
ProKidney Corp. 420.55 Million USD 97.38%
Applied Therapeutics, Inc. 54.83 Million USD 79.906%
Hoth Therapeutics, Inc. 9.52 Million USD -15.732%
BridgeBio Pharma, Inc. 546.38 Million USD 97.983%
CorMedix Inc. 82.05 Million USD 86.573%
BioLineRx Ltd. 63.92 Million USD 82.764%
Tango Therapeutics, Inc. 402.56 Million USD 97.263%
Galectin Therapeutics Inc. 28.2 Million USD 60.929%
Atai Life Sciences N.V. 293.47 Million USD 96.246%
Renovaro Biosciences Inc. 163.12 Million USD 93.246%
Aerovate Therapeutics, Inc. 127.41 Million USD 91.353%
Zentalis Pharmaceuticals, Inc. 562.02 Million USD 98.04%
Sagimet Biosciences Inc. 96.71 Million USD 88.608%
MediciNova, Inc. 66.26 Million USD 83.374%
Praxis Precision Medicines, Inc. 87.94 Million USD 87.472%
Cardio Diagnostics Holdings, Inc. 4.46 Million USD -146.909%
GeoVax Labs, Inc. 9.28 Million USD -18.687%
Axsome Therapeutics, Inc. 588.23 Million USD 98.127%
Biomea Fusion, Inc. 199.92 Million USD 94.489%
PTC Therapeutics, Inc. 1.9 Billion USD 99.421%
Mereo BioPharma Group plc 66.49 Million USD 83.431%
Cullinan Oncology, Inc. 485.09 Million USD 97.729%
Syndax Pharmaceuticals, Inc. 612.88 Million USD 98.202%
Absci Corporation 234.48 Million USD 95.301%
NRx Pharmaceuticals, Inc. 7.31 Million USD -50.622%
4D Molecular Therapeutics, Inc. 339.89 Million USD 96.758%
Dyne Therapeutics, Inc. 165.08 Million USD 93.326%
Kiniksa Pharmaceuticals, Ltd. 526.32 Million USD 97.907%
Ventyx Biosciences, Inc. 277.69 Million USD 96.032%
Allakos Inc. 243.61 Million USD 95.477%
Imunon, Inc. 21.91 Million USD 49.731%
Fulcrum Therapeutics, Inc. 257.69 Million USD 95.724%
Corcept Therapeutics Incorporated 621.51 Million USD 98.227%
BioAtla, Inc. 119.65 Million USD 90.792%
NLS Pharmaceutics AG 1.84 Million USD -496.651%
Bio-Path Holdings, Inc. 3.22 Million USD -242.174%
Allogene Therapeutics, Inc. 642.83 Million USD 98.286%
Larimar Therapeutics, Inc. 95.93 Million USD 88.515%
XOMA Corporation 234.3 Million USD 95.298%
Kezar Life Sciences, Inc. 221.23 Million USD 95.02%
Cara Therapeutics, Inc. 125.84 Million USD 91.245%
aTyr Pharma, Inc. 122.06 Million USD 90.974%
Aligos Therapeutics, Inc. 153.9 Million USD 92.841%
Akero Therapeutics, Inc. 580.27 Million USD 98.101%
Viridian Therapeutics, Inc. 490.42 Million USD 97.753%
Eliem Therapeutics, Inc. 110.46 Million USD 90.026%
EyeGate Pharmaceuticals, Inc. 15.15 Million USD 27.31%
Akari Therapeutics, Plc 4.35 Million USD -152.997%
Tevogen Bio Holdings Inc. 17.03 Million USD 35.33%
Halozyme Therapeutics, Inc. 1.73 Billion USD 99.364%
Lexaria Bioscience Corp. 3.08 Million USD -257.265%
UroGen Pharma Ltd. 178.31 Million USD 93.821%
Sutro Biopharma, Inc. 470.73 Million USD 97.659%
ZIVO Bioscience, Inc. 555.71 Thousand USD -1882.671%
Orgenesis Inc. 14.55 Million USD 24.285%
Entera Bio Ltd. 11.76 Million USD 6.349%
GH Research PLC 226.3 Million USD 95.131%
Lisata Therapeutics, Inc. 54.69 Million USD 79.855%
Reneo Pharmaceuticals, Inc. 107.43 Million USD 89.745%
Xencor, Inc. 952.69 Million USD 98.843%
60 Degrees Pharmaceuticals, Inc. 7.78 Million USD -41.551%
Replimune Group, Inc. 487.72 Million USD 97.741%
Coeptis Therapeutics Holdings, Inc. 8.07 Million USD -36.512%
Vanda Pharmaceuticals Inc. 648.44 Million USD 98.301%
Lexaria Bioscience Corp. 3.08 Million USD -257.265%
Portage Biotech Inc. 7.77 Million USD -41.638%
Cardio Diagnostics Holdings, Inc. 4.46 Million USD -146.909%
Olema Pharmaceuticals, Inc. 276.94 Million USD 96.022%
OncoCyte Corporation 74.89 Million USD 85.288%
Qualigen Therapeutics, Inc. 2.03 Million USD -441.892%
Processa Pharmaceuticals, Inc. 5.78 Million USD -90.404%
Purple Biotech Ltd. 44.3 Million USD 75.13%
CollPlant Biotechnologies Ltd. 34.12 Million USD 67.714%
scPharmaceuticals Inc. 94.47 Million USD 88.338%
ProMIS Neurosciences, Inc. 18.04 Million USD 38.941%
HilleVax, Inc. 344.43 Million USD 96.801%
NeuroSense Therapeutics Ltd. 3.17 Million USD -246.914%
Tharimmune, Inc. 10.94 Million USD -0.654%
Genprex, Inc. 10.67 Million USD -3.256%
Neumora Therapeutics, Inc. Common Stock 496.19 Million USD 97.78%
Atossa Therapeutics, Inc. 96.25 Million USD 88.553%
XTL Biopharmaceuticals Ltd. 2.42 Million USD -354.163%
Virios Therapeutics, Inc. 4.16 Million USD -164.51%
OKYO Pharma Limited 1.54 Million USD -614.868%
Savara Inc. 177.56 Million USD 93.795%
Curis, Inc. 77.28 Million USD 85.743%
Daré Bioscience, Inc. 21.28 Million USD 48.229%
Carmell Therapeutics Corporation 63.94 Million USD 82.771%
Titan Pharmaceuticals, Inc. 8.08 Million USD -36.26%
Achieve Life Sciences, Inc. 19.37 Million USD 43.121%
BeiGene, Ltd. 5.8 Billion USD 99.81%
Kiromic BioPharma, Inc. 12.16 Million USD 9.458%
Revolution Medicines, Inc. Warrant 2.08 Billion USD 99.472%
Protagonist Therapeutics, Inc. 357.95 Million USD 96.922%
Erasca, Inc. 395.29 Million USD 97.213%
bluebird bio, Inc. 619.16 Million USD 98.22%
Protagenic Therapeutics, Inc. 4.32 Million USD -154.848%
BioMarin Pharmaceutical Inc. 6.84 Billion USD 99.839%
DBV Technologies S.A. 182.98 Million USD 93.979%
Protagenic Therapeutics, Inc. 4.32 Million USD -154.848%
Moderna, Inc. 18.42 Billion USD 99.94%
Vincerx Pharma, Inc. 18.21 Million USD 39.518%
Fresh Tracks Therapeutics, Inc. 11.58 Million USD 4.902%
Molecular Templates, Inc. 35.38 Million USD 68.861%
Acrivon Therapeutics, Inc. Common Stock 138.26 Million USD 92.031%
Travere Therapeutics, Inc. 788.91 Million USD 98.603%
Monte Rosa Therapeutics, Inc. 303.75 Million USD 96.373%
Spruce Biosciences, Inc. 103.94 Million USD 89.4%
Celldex Therapeutics, Inc. 465.62 Million USD 97.634%
Cogent Biosciences, Inc. 313.43 Million USD 96.485%
MacroGenics, Inc. 306.82 Million USD 96.409%
RenovoRx, Inc. 1.46 Million USD -651.569%
Adicet Bio, Inc. 207.29 Million USD 94.685%
Prime Medicine, Inc. 193.85 Million USD 94.316%
Aditxt, Inc. 44.57 Million USD 75.284%
Adagene Inc. 115.72 Million USD 90.479%
Estrella Immunopharma, Inc. 4.45 Million USD -147.363%
Quantum-Si incorporated 298.25 Million USD 96.306%
Maravai LifeSciences Holdings, Inc. 1.48 Billion USD 99.259%
Acurx Pharmaceuticals, Inc. 7.7 Million USD -42.922%
Voyager Therapeutics, Inc. 351.28 Million USD 96.863%
SciSparc Ltd. 11.18 Million USD 1.467%
Vericel Corporation 353.65 Million USD 96.885%
Revelation Biosciences, Inc. 12.21 Million USD 9.782%
Minerva Neurosciences, Inc. 56.9 Million USD 80.636%
Generation Bio Co. 374.75 Million USD 97.06%
Astria Therapeutics, Inc. 254.66 Million USD 95.674%
Black Diamond Therapeutics, Inc. 158.56 Million USD 93.052%
Arcutis Biotherapeutics, Inc. 341.36 Million USD 96.772%
Invivyd, Inc. 229.18 Million USD 95.192%
Relay Therapeutics, Inc. 843.98 Million USD 98.695%
Quoin Pharmaceuticals, Ltd. 12.16 Million USD 9.461%
Spero Therapeutics, Inc. 182.39 Million USD 93.959%
Artelo Biosciences, Inc. 20.42 Million USD 46.054%
2seventy bio, Inc. 565.42 Million USD 98.051%
ADMA Biologics, Inc. 329.18 Million USD 96.653%
Clene Inc. 52.34 Million USD 78.95%
Capricor Therapeutics, Inc. 58.73 Million USD 81.241%
Boundless Bio, Inc. Common Stock 129.89 Million USD 91.518%
GeoVax Labs, Inc. 9.28 Million USD -18.687%
Recursion Pharmaceuticals, Inc. 653.69 Million USD 98.315%
Citius Pharmaceuticals, Inc. 103.61 Million USD 89.366%
Contineum Therapeutics, Inc. Class A Common Stock 130.38 Million USD 91.55%
Relmada Therapeutics, Inc. 97.55 Million USD 88.706%
Finch Therapeutics Group, Inc. 70.99 Million USD 84.481%
ALX Oncology Holdings Inc. 242.55 Million USD 95.457%
Vir Biotechnology, Inc. 1.96 Billion USD 99.438%
Evaxion Biotech A/S 12.88 Million USD 14.514%
Ocular Therapeutix, Inc. 252.06 Million USD 95.629%
Verve Therapeutics, Inc. 752.68 Million USD 98.536%
Trevena, Inc. 40.6 Million USD 72.865%
Surrozen, Inc. 46.08 Million USD 76.089%
Tyra Biosciences, Inc. 225.85 Million USD 95.122%
Cingulate Inc. 3.49 Million USD -215.572%
Galmed Pharmaceuticals Ltd. 16.62 Million USD 33.742%
Unity Biotechnology, Inc. 65.69 Million USD 83.227%
Tenax Therapeutics, Inc. 11.68 Million USD 5.705%
Terns Pharmaceuticals, Inc. 268.51 Million USD 95.897%
ACADIA Pharmaceuticals Inc. 748.95 Million USD 98.529%
Connect Biopharma Holdings Limited 125.89 Million USD 91.248%
Clearmind Medicine Inc. 4.32 Million USD -154.787%
Kronos Bio, Inc. 213.27 Million USD 94.834%
Bolt Biotherapeutics, Inc. 159.78 Million USD 93.104%
CERo Therapeutics Holdings, Inc. 8.56 Million USD -28.706%
Viking Therapeutics, Inc. 368.49 Million USD 97.01%
Statera Biopharma, Inc. 21.16 Million USD 47.954%
ImmunityBio, Inc. 504.45 Million USD 97.816%
Korro Bio, Inc. 221.66 Million USD 95.029%
Kineta, Inc. 10.28 Million USD -7.169%
BioVie Inc. 25.2 Million USD 56.292%
Codexis, Inc. 136.56 Million USD 91.932%
Celularity Inc. 143.88 Million USD 92.343%
Crinetics Pharmaceuticals, Inc. 635.35 Million USD 98.266%
Celcuity Inc. 191.21 Million USD 94.238%
Virax Biolabs Group Limited 5.48 Million USD -100.913%
Cibus, Inc. 544.41 Million USD 97.976%
Eledon Pharmaceuticals, Inc. 125.89 Million USD 91.248%
eFFECTOR Therapeutics, Inc. 20.54 Million USD 46.369%
IN8bio, Inc. 33.7 Million USD 67.314%
Kodiak Sciences Inc. 479.37 Million USD 97.702%
Annexon, Inc. 297.67 Million USD 96.299%
Adverum Biotechnologies, Inc. 173.01 Million USD 93.632%
Assembly Biosciences, Inc. 137.46 Million USD 91.985%
Avalo Therapeutics, Inc. 20.99 Million USD 47.516%
Ionis Pharmaceuticals, Inc. 2.99 Billion USD 99.632%
Eyenovia, Inc. 28.77 Million USD 61.716%
Puma Biotechnology, Inc. 230.52 Million USD 95.221%
Conduit Pharmaceuticals Inc. 7.22 Million USD -52.519%
Xilio Therapeutics, Inc. 60.92 Million USD 81.916%
Arcellx, Inc. 825.13 Million USD 98.665%
Cardiff Oncology, Inc. 81.63 Million USD 86.504%
Enanta Pharmaceuticals, Inc. 462.27 Million USD 97.617%
Regulus Therapeutics Inc. 30.75 Million USD 64.169%
Moolec Science SA 24.05 Million USD 54.19%
Acumen Pharmaceuticals, Inc. 310.12 Million USD 96.447%
Geron Corporation 394.07 Million USD 97.204%
LAVA Therapeutics N.V. 101.71 Million USD 89.167%
Royalty Pharma plc 16.38 Billion USD 99.933%
Atea Pharmaceuticals, Inc. 594.96 Million USD 98.148%
Greenwich LifeSciences, Inc. 6.99 Million USD -57.517%
TFF Pharmaceuticals, Inc. 12.02 Million USD 8.392%
Mersana Therapeutics, Inc. 226.06 Million USD 95.126%
Humacyte, Inc. 128.22 Million USD 91.407%
Structure Therapeutics Inc. 482.01 Million USD 97.714%
89bio, Inc. 596.26 Million USD 98.152%
PMV Pharmaceuticals, Inc. 252.15 Million USD 95.63%
Avenue Therapeutics, Inc. 1.85 Million USD -495.568%
Genelux Corporation 27.89 Million USD 60.499%
Trevi Therapeutics, Inc. 89.4 Million USD 87.676%
Lexicon Pharmaceuticals, Inc. 229.42 Million USD 95.198%
Notable Labs, Ltd. 19.54 Million USD 43.616%
Liquidia Corporation 120.43 Million USD 90.851%
Mustang Bio, Inc. 17.74 Million USD 37.899%
Immunovant, Inc. 666.71 Million USD 98.347%
Quantum-Si incorporated 298.25 Million USD 96.306%
Arbutus Biopharma Corporation 144.4 Million USD 92.37%
DiaMedica Therapeutics Inc. 54.16 Million USD 79.657%
Vera Therapeutics, Inc. 175.54 Million USD 93.724%
Acasti Pharma Inc. 73.3 Million USD 84.969%
MiNK Therapeutics, Inc. 4.55 Million USD -142.033%
Pasithea Therapeutics Corp. 26.11 Million USD 57.813%
Xenon Pharmaceuticals Inc. 964.79 Million USD 98.858%
Elevai Labs, Inc. Common Stock 5.18 Million USD -112.296%
NeuroBo Pharmaceuticals, Inc. 22.78 Million USD 51.635%
Tempest Therapeutics, Inc. 51.6 Million USD 78.649%
Soleno Therapeutics, Inc. 180.69 Million USD 93.902%
PepGen Inc. 143.05 Million USD 92.298%
Moleculin Biotech, Inc. 38.21 Million USD 71.17%
United Therapeutics Corporation 7.16 Billion USD 99.846%
Nuvectis Pharma, Inc. 19.18 Million USD 42.57%
Solid Biosciences Inc. 164.93 Million USD 93.32%
BriaCell Therapeutics Corp. 5.87 Million USD -87.628%
Immuneering Corporation 102.58 Million USD 89.26%
Lixte Biotechnology Holdings, Inc. 4.3 Million USD -155.72%
Silo Pharma, Inc. 7.74 Million USD -42.239%
Belite Bio, Inc 94.64 Million USD 88.358%
XOMA Corporation 234.3 Million USD 95.298%
ARS Pharmaceuticals, Inc. 233.18 Million USD 95.275%
Bionomics Limited 27.64 Million USD 60.151%
Apogee Therapeutics, Inc. 401.4 Million USD 97.255%
Alpha Tau Medical Ltd. 107.38 Million USD 89.74%
uniQure N.V. 831.68 Million USD 98.675%
Cassava Sciences, Inc. 151.66 Million USD 92.735%
Estrella Immunopharma, Inc. 4.45 Million USD -147.363%
Poseida Therapeutics, Inc. 273.88 Million USD 95.977%
Forte Biosciences, Inc. 38.98 Million USD 71.734%
Anebulo Pharmaceuticals, Inc. 4.07 Million USD -170.506%
Enlivex Therapeutics Ltd. 36.83 Million USD 70.085%
Conduit Pharmaceuticals Inc. 7.22 Million USD -52.519%
SeaStar Medical Holding Corporation 3.51 Million USD -213.635%
FibroBiologics, Inc. Common Stock 11.82 Million USD 6.793%
Altimmune, Inc. 210.64 Million USD 94.769%
Amicus Therapeutics, Inc. 777.88 Million USD 98.584%
Alpha Tau Medical Ltd. 107.38 Million USD 89.74%
Compugen Ltd. 121.33 Million USD 90.919%
Peak Bio, Inc. 2.59 Million USD -324.354%
Zevra Therapeutics, Inc. 172.32 Million USD 93.606%
Benitec Biopharma Inc. 52.21 Million USD 78.897%
Spyre Therapeutics, Inc. 341.85 Million USD 96.777%
NKGen Biotech, Inc. Common Stock 34.77 Million USD 68.314%
Zura Bio Limited 100.84 Million USD 89.074%
PolyPid Ltd. 15.37 Million USD 28.324%
Aileron Therapeutics, Inc. 119.28 Million USD 90.763%
NKGen Biotech, Inc. Warrants 34.77 Million USD 68.314%
Instil Bio, Inc. 325.63 Million USD 96.616%
argenx SE 4.54 Billion USD 99.757%
Immunome, Inc. 148.54 Million USD 92.582%
Compass Therapeutics, Inc. 156.87 Million USD 92.977%
Verona Pharma plc 308.12 Million USD 96.424%
enGene Holdings Inc. Warrants 86.95 Million USD 87.33%
Shattuck Labs, Inc. 159.56 Million USD 93.095%
CervoMed Inc. 9.97 Million USD -10.484%
LENZ Therapeutics, Inc. 188.45 Million USD 94.154%
Plus Therapeutics, Inc. 11.38 Million USD 3.249%
Dianthus Therapeutics, Inc. 179.4 Million USD 93.859%
Moolec Science SA 24.05 Million USD 54.19%
Enveric Biosciences, Inc. 6.11 Million USD -80.107%
Inovio Pharmaceuticals, Inc. 172.94 Million USD 93.629%
AnaptysBio, Inc. 452.38 Million USD 97.564%
Design Therapeutics, Inc. 289.64 Million USD 96.196%
Leap Therapeutics, Inc. 72.82 Million USD 84.871%
NeurAxis, Inc. 509.49 Thousand USD -2062.521%
Seelos Therapeutics, Inc. 5.41 Million USD -103.359%
Lumos Pharma, Inc. 40.63 Million USD 72.887%
Achilles Therapeutics plc 161.45 Million USD 93.176%
enGene Holdings Inc. Common Stock 86.95 Million USD 87.33%
180 Life Sciences Corp. 5.25 Million USD -109.489%
Opiant Pharmaceuticals, Inc. 70.42 Million USD 84.356%
CERo Therapeutics Holdings, Inc. 8.56 Million USD -28.706%
Nutriband Inc. 7.51 Million USD -46.571%
ORIC Pharmaceuticals, Inc. 254.68 Million USD 95.674%
CG Oncology, Inc. Common stock 199.3 Million USD 94.472%
Fractyl Health, Inc. Common Stock 76.21 Million USD 85.543%
Rani Therapeutics Holdings, Inc. 57.91 Million USD 80.976%
MoonLake Immunotherapeutics 526.54 Million USD 97.907%
Palisade Bio, Inc. 14.05 Million USD 21.591%
Tourmaline Bio, Inc. 210.29 Million USD 94.761%
Beam Therapeutics Inc. 1.45 Billion USD 99.245%
Neurogene Inc. 222.57 Million USD 95.05%
Mirum Pharmaceuticals, Inc. 646.62 Million USD 98.296%
AEON Biopharma, Inc. 6.84 Million USD -60.964%
CARGO Therapeutics, Inc. Common Stock 453.03 Million USD 97.568%
Sesen Bio, Inc. 189.17 Million USD 94.176%
Enliven Therapeutics, Inc. 271.86 Million USD 95.947%
Kiora Pharmaceuticals, Inc. 13.71 Million USD 19.646%
Iovance Biotherapeutics, Inc. 780.35 Million USD 98.588%
Taysha Gene Therapies, Inc. 266.99 Million USD 95.873%
Athira Pharma, Inc. 160.24 Million USD 93.124%
Vaccinex, Inc. 3.63 Million USD -203.443%
HCW Biologics Inc. 28.51 Million USD 61.359%
XOMA Corporation 234.3 Million USD 95.298%
Nektar Therapeutics 398.03 Million USD 97.232%
Arvinas, Inc. 1.3 Billion USD 99.155%
Tevogen Bio Holdings Inc. 17.03 Million USD 35.33%
Merus N.V. 458.49 Million USD 97.597%
Omega Therapeutics, Inc. 204.36 Million USD 94.609%
Quince Therapeutics, Inc. 180.2 Million USD 93.886%
Rezolute, Inc. 132.73 Million USD 91.699%
Clene Inc. 52.34 Million USD 78.95%
Indaptus Therapeutics, Inc. 14.92 Million USD 26.172%
BeyondSpring Inc. 24.8 Million USD 55.587%
Synlogic, Inc. 75.55 Million USD 85.416%
Allarity Therapeutics, Inc. 11.86 Million USD 7.115%
Phio Pharmaceuticals Corp. 9.36 Million USD -17.663%
Peak Bio, Inc. 2.59 Million USD -324.354%
Werewolf Therapeutics, Inc. 174.83 Million USD 93.698%
Krystal Biotech, Inc. 818.35 Million USD 98.654%
Karyopharm Therapeutics Inc. 240.43 Million USD 95.418%
SpringWorks Therapeutics, Inc. 725.78 Million USD 98.482%
Lipella Pharmaceuticals Inc. 3.57 Million USD -208.009%
MannKind Corporation 475.19 Million USD 97.681%
Ikena Oncology, Inc. 192.09 Million USD 94.264%
Cyclerion Therapeutics, Inc. 13.37 Million USD 17.616%
Gyre Therapeutics, Inc. 116.53 Million USD 90.546%
Gossamer Bio, Inc. 311.91 Million USD 96.468%
CohBar, Inc. 16.36 Million USD 32.676%
Cognition Therapeutics, Inc. 35.16 Million USD 68.666%
NRx Pharmaceuticals, Inc. 7.31 Million USD -50.622%
Legend Biotech Corporation 1.84 Billion USD 99.404%
Mural Oncology plc 301.74 Million USD 96.349%
Biora Therapeutics, Inc. 31.21 Million USD 64.703%
PaxMedica, Inc. Common Stock 5.68 Million USD -93.965%
Disc Medicine, Inc. 367.99 Million USD 97.006%
Champions Oncology, Inc. 26.13 Million USD 57.837%
REGENXBIO Inc. 573.97 Million USD 98.08%
Ensysce Biosciences, Inc. 2.7 Million USD -306.856%
Anavex Life Sciences Corp. 154.38 Million USD 92.863%
Cellectar Biosciences, Inc. 12.07 Million USD 8.758%
Edgewise Therapeutics, Inc. 340.03 Million USD 96.76%
Vaxart, Inc. 91.83 Million USD 88.002%
PharmaCyte Biotech, Inc. 59.9 Million USD 81.607%
Aldeyra Therapeutics, Inc. 148.32 Million USD 92.572%
Cellectis S.A. 334.27 Million USD 96.704%
Longeveron Inc. 12.17 Million USD 9.525%
Repare Therapeutics Inc. 253.9 Million USD 95.661%
Sarepta Therapeutics, Inc. 3.26 Billion USD 99.662%
Inozyme Pharma, Inc. 200.84 Million USD 94.514%
Revolution Medicines, Inc. 2.08 Billion USD 99.472%
Nymox Pharmaceutical Corporation 1.62 Million USD -578.031%
Third Harmonic Bio, Inc. 277.71 Million USD 96.033%
ArriVent BioPharma, Inc. Common Stock 163.09 Million USD 93.245%
AN2 Therapeutics, Inc. 138.74 Million USD 92.059%
Anixa Biosciences, Inc. 25.52 Million USD 56.829%
Vertex Pharmaceuticals Incorporated 22.73 Billion USD 99.952%
Denali Therapeutics Inc. 1.15 Billion USD 99.045%
Revelation Biosciences, Inc. 12.21 Million USD 9.782%
Veru Inc. 50.59 Million USD 78.224%
Corvus Pharmaceuticals, Inc. 45.55 Million USD 75.813%
Cingulate Inc. 3.49 Million USD -215.572%
Passage Bio, Inc. 150.54 Million USD 92.681%
Context Therapeutics Inc. 16.06 Million USD 31.406%
Exicure, Inc. 11.58 Million USD 4.853%
Day One Biopharmaceuticals, Inc. 376.04 Million USD 97.07%
Oramed Pharmaceuticals Inc. 161.64 Million USD 93.184%
Scinai Immunotherapeutics Ltd. 17.47 Million USD 36.939%
Rhythm Pharmaceuticals, Inc. 332.74 Million USD 96.689%
Nuvalent, Inc. 732.38 Million USD 98.496%
ABVC BioPharma, Inc. 14.94 Million USD 26.272%
Carisma Therapeutics, Inc. 89.55 Million USD 87.697%
Unicycive Therapeutics, Inc. 14.19 Million USD 22.359%
OmniAb, Inc. 401.98 Million USD 97.259%
Anew Medical, Inc. 19.45 Million USD 43.37%
Fennec Pharmaceuticals Inc. 26.72 Million USD 58.775%
Lipocine Inc. 23 Million USD 52.098%
Lexeo Therapeutics, Inc. Common Stock 139.8 Million USD 92.119%
Nautilus Biotechnology, Inc. 305.56 Million USD 96.394%
SAB Biotherapeutics, Inc. 83.94 Million USD 86.874%
G1 Therapeutics, Inc. 121.54 Million USD 90.935%
Bellerophon Therapeutics, Inc. 7.93 Million USD -38.853%
Sage Therapeutics, Inc. 882.27 Million USD 98.751%
Ocugen, Inc. 64.54 Million USD 82.93%
Mind Medicine (MindMed) Inc. 124.54 Million USD 91.153%
Q32 Bio Inc. 306.11 Million USD 96.401%
Brainstorm Cell Therapeutics Inc. 4.2 Million USD -161.835%
Alumis Inc. Common Stock 89.61 Million USD 87.705%
Equillium, Inc. 50.53 Million USD 78.195%
Kyverna Therapeutics, Inc. 75.19 Million USD 85.347%
Coya Therapeutics, Inc. 41.27 Million USD 73.305%
CNS Pharmaceuticals, Inc. 1.7 Million USD -547.793%
Galera Therapeutics, Inc. 26.14 Million USD 57.852%
Evelo Biosciences, Inc. 64.44 Million USD 82.902%
Comera Life Sciences Holdings, Inc. 3.72 Million USD -195.618%
Dominari Holdings Inc. 57.55 Million USD 80.858%
Edesa Biotech, Inc. 8.89 Million USD -23.931%
Bio-Techne Corporation 2.81 Billion USD 99.608%
Agios Pharmaceuticals, Inc. 937.11 Million USD 98.824%
Harmony Biosciences Holdings, Inc. 811.44 Million USD 98.642%
Prelude Therapeutics Incorporated 277.66 Million USD 96.032%
Candel Therapeutics, Inc. 41.7 Million USD 73.579%
iTeos Therapeutics, Inc. 667.58 Million USD 98.35%
Nkarta, Inc. 378.88 Million USD 97.092%
BioCardia, Inc. 2.98 Million USD -268.865%
Iterum Therapeutics plc 26.25 Million USD 58.041%